Showing results (1221-1230 of 1,247) with videos related to
Sort By:
Pageof 125
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.The Journal of Clinical Investigation|December 1, 2022
Chronic viral coinfections differentially affect the likelihood of developing long COVIDMichael J Peluso, Tyler-Marie Deveau, Sadie E Munter, et al.Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVIDMichael J Peluso, Tyler-Marie Deveau, Sadie E Munter, et al.Journal of Medicinal Chemistry|November 13, 2013
Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivoPravin S Shirude, Radha Shandil, Claire Sadler, et al.Nature Communications|January 23, 2021
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaquesYashavanth Shaan Lakshmanappa, Sonny R Elizaldi, Jamin W Roh, et al.Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Dynamics and significance of the antibody response to SARS-CoV-2 infectionAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.Science Immunology|October 9, 2020
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.Mbio|April 23, 2015
Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillasHannah J Barbian, Julie M Decker, Frederic Bibollet-Ruche, et al.Plos Pathogens|April 20, 2022
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.Journal of Medicinal Chemistry|June 11, 2014
Aminoazabenzimidazoles, a novel class of orally active antimalarial agentsShahul Hameed P, Murugan Chinnapattu, Gajanan Shanbag, et al.Pageof 125